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Spontaneous vesicular transmitter release
A B S T R A C T
Down syndrome (DS) is characterised by abnormal cognitive and motor development, and later in life by pro-
gressive Alzheimer's disease (AD)-like dementia, neuropathology, declining motor function and shorter life
expectancy. It is caused by trisomy of chromosome 21 (Hsa21), but how individual Hsa21 genes contribute to
various aspects of the disorder is incompletely understood. Previous work has demonstrated a role for tripli-
cation of the Hsa21 gene DYRK1A in cognitive and motor deficits, as well as in altered neurogenesis and neu-
rofibrillary degeneration in the DS brain, but its contribution to other DS phenotypes is unclear. Here we de-
monstrate that overexpression of minibrain (mnb), the Drosophila ortholog of DYRK1A, in the Drosophila nervous
system accelerated age-dependent decline in motor performance and shortened lifespan. Overexpression of mnb
in the eye was neurotoxic and overexpression in ellipsoid body neurons in the brain caused age-dependent
neurodegeneration. At the larval neuromuscular junction, an established model for mammalian central gluta-
matergic synapses, neuronal mnb overexpression enhanced spontaneous vesicular transmitter release. It also
slowed recovery from short-term depression of evoked transmitter release induced by high-frequency nerve
stimulation and increased the number of boutons in one of the two glutamatergic motor neurons innervating the
muscle. These results provide further insight into the roles of DYRK1A triplication in abnormal aging and sy-
naptic dysfunction in DS.
1. Introduction
Down syndrome (DS, also known as Down's syndrome) or trisomy
21 is caused by the presence of three copies of chromosome 21 (Hsa21)
instead of the usual two (Herault et al., 2017). It is characterised by
cognitive impairment (Lott and Dierssen, 2010) and the delayed and
incomplete acquisition of motor skills (Malak et al., 2015) as a result of
abnormal development of the nervous system (Stagni et al., 2018).
Individuals with DS almost invariably develop Alzheimer's disease
(AD)-like symptoms (AD-DS). These include progressive dementia after
40 years of age, the onset of amyloid plaques, neurofibrillary tangles
(NFTs) and neurodegeneration after 10–20 years (Wiseman et al., 2015;
Zigman, 2013), faster age-dependent motor decline that is an early
marker for the onset of cognitive decline and health deterioration
(Anderson-Mooney et al., 2016; Buchman and Bennett, 2011), and a
shorter mean life expectancy by approximately 28 years (O'Leary et al.,
2018). Currently there is no treatment for DS or AD; our understanding
of the mechanisms of the disorder is incomplete and this hampers the
development of effective therapies.
One of the Hsa21 genes, DYRK1A (dual specificity tyrosine-phos-
phorylation-regulated kinase 1A), is a candidate causative gene for the
structural and functional changes that occur in the DS brain, and for the
associated cognitive and motor deficits (Herault et al., 2017; Stagni
et al., 2018). DYRK1A/Dyrk1a mRNA and protein are expressed
throughout the brain in humans and rodents, wherein DYRK1A controls
aspects of neuronal development and function (Duchon and Herault,
2016; Kay et al., 2016; Stringer et al., 2017). DYRK1A/Dyrk1a mRNA
and protein expression is increased in DS brain and in the brain of
different mouse models of DS (Duchon and Herault, 2016; Garcia-Cerro
et al., 2018; Kay et al., 2016; Stringer et al., 2017), whether the gene is
triplicated as part of a genomic segment, as in Dp1Yey, Ts65Dn, Ts1Cje
and Tc1 mice, or alone as in TgDyrk1a and TgDYRK1A mice (Herault
et al., 2017).
DS-associated cognitive and motor deficits are replicated by over-
expression of Dyr1ka in mice (Ahn et al., 2006; Altafaj et al., 2001;
Altafaj et al., 2013; Arque et al., 2013; García-Cerro et al., 2014; Garcia-
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Cerro et al., 2018; Martínez de Lagrán et al. 2004; Ortiz-Abalia et al.,
2008; Souchet et al., 2014; Watson-Scales et al., 2018). However, the
contribution of DYRK1A overexpression to the shorter life expectancy,
faster age-dependent decline in cognitive and motor function, and de-
velopment of AD-like pathology in DS is unclear. It is predicted to play a
role as it both phosphorylates tau and alters its splicing (Shi et al., 2008;
Woods et al., 2001), promoting its self-aggregation (Liu et al., 2008)
into NFTs. Dyrk1A is found physically associated with NFTs in the brain
to a greater level in DS-AD than non-DS associated AD (Wegiel et al.,
2008; Wegiel et al., 2011). In the Ts65Dn and Ts1Cje mouse models of
DS, Dyrk1a overexpression in the brain intensifies with age (Ahmed
et al., 2017; Creau et al., 2016; Stringer et al., 2017; Watson-Scales
et al., 2018), and this is associated with AD-DS-like histopathological
changes in the aged Ts65Dn brain (García-Cerro et al., 2017; Wiseman
et al., 2015). However, there is insufficient behavioural data from aged
animals to directly assess the impact of DYRK1A overexpression in in-
ducing DS-AD phenotypes.
Cognitive and motor dysfunction in individuals with DS and in
mouse models of DS are associated with changes in synaptic plasticity
and with changes in the number and structure of GABAergic and glu-
tamatergic brain neurons and synapses (Battaglia et al., 2008;
Contestabile et al., 2017; Duchon and Herault, 2016). Such modifica-
tions have been linked to Dyrk1a overexpression (Duchon and Herault,
2016; García-Cerro et al., 2017; Garcia-Cerro et al., 2018; Ruiz-Mejias
et al., 2016), but the effects of Dyrk1a overexpression on the basic
properties of synaptic function have rarely been explored. In one study,
there was no change in the frequency of miniature excitatory synaptic
currents (mEPSCs) or the probability of electrically-evoked glutamate
release in the prefrontal cortex of TgDyrk1a mice (Thomazeau et al.,
2014). Nevertheless, since Dyrk1a controls the activity of proteins that
regulate endocytosis (Murakami et al., 2012) and DYRK1A over-
expression slows endocytosis of transmitter vesicles in hippocampal
presynaptic membranes from TgDYRK1A mice (Kim et al., 2010),
modulation of transmitter release at other glutamatergic synapses is
likely.
To investigate the contribution of DYRK1A overexpression in the
nervous system to various aspects of DS, we overexpressed minibrain
(mnb), the Drosophila ortholog of DYRK1A (Duchon and Herault, 2016),
in the Drosophila nervous system and implemented well-established
assays in larvae and adult flies (Bykhovskaia and Vasin, 2017; Lenz
et al., 2013; McGurk et al., 2015). The assays monitored motor im-
pairment and its development with age, lifespan, age-related neurode-
generation, and synaptic dysfunction. Due to their short lifecycle,
Drosophila are one of the pre-eminent models for aging and neurode-
generation (Jones and Grotewiel, 2011), both aspects of DS that are
more difficult to investigate in mice. The Drosophila larval neuromus-
cular junction (NMJ) is a well-established model for mammalian central
glutamatergic synapses and is easily accessible to electrophysiology
(Bykhovskaia and Vasin, 2017). Mnb is expressed presynaptically at
larval NMJs and reducing its expression changes motor nerve terminal
structure and impairs recycling of transmitter vesicles, while over-
expression of one isoform, mnbeF, has no effect on basal transmission
but ameliorates the effects of reduced mnb expression (Chen et al.,
2014). Five mnb isoforms, E-I, have been identified, all of which share a
highly conserved kinase domain (Gramates et al., 2017; Hong et al.,
2012). Regions of DYRK1A outside the kinase domain also appear to
play important roles, but which areas exactly and how they impact
function is thus far incompletely understood (Jin et al., 2015; Kelly and
Rahmani, 2005; von Groote-Bidlingmaier et al., 2003). We therefore
utilised mnbeH, the isoform with the longest coding region (Gramates
et al., 2017; Zerbino et al., 2018). Here we report the effects of neuronal
overexpression of mnb-H on motor function, the rate of motor decline
with age, lifespan, age-related neurodegeneration, presynaptic struc-
ture, spontaneous transmitter release and recovery from frequency-
dependent depression of electrically-evoked transmitter release.
2. Results
2.1. Neuronal overexpression of mnb produced motor deficits in larvae,
accelerated age-dependent motor decline in adult flies and shortened adult
lifespan
The effect of mnb overexpression in the nervous system on motor
function (specifically the mnb-H splice variant) was tested using two
assays of fly larval locomotion. Elav > mnb larvae, overexpressing mnb
throughout the nervous system under the control of the Elav-Gal4 driver
(Robinow and White, 1991), did not move as far as control larvae (Elav/
+) in a free movement assay (Fig. 1A), which measures the ability of
larvae to perform rhythmic muscle contractions necessary for gross
locomotion (Kohsaka et al., 2017). They also took longer to complete a
self-righting assay (Fig. 1B), which is a more complex motor task re-
quiring larvae to enact a co-ordinated sequence of movements to right
themselves after being rolled onto their backs (Picao-Osorio et al.,
2015). To assess the impact of neuronal mnb overexpression on age-
related decline in locomotor function, the performance of the same
cohorts of adult flies was assessed in a negative geotaxis assay at dif-
ferent ages (Jones and Grotewiel, 2011). This showed acceleration in
Elav > mnb flies of the usual age-related decline in performance (Elav/
+). There was also evident shortening of the lifespan of Elav > mnb
flies, so that the median lifespan was reduced by almost 50% (Elav/+,
Fig. 1. Motor deficits in larvae, accelerated age-dependent motor decline in
adult flies and shortened adult lifespan due to neuronal overexpression of mnb.
(A) Elav > mnb larvae crossed fewer lines of a 0.5 cm grid in 60 s than control
larvae (Elav/+, 14.7 ± 0.44, n=15; Elav > mnb, 12.1 ± 0.86, n=15;
mean ± SEM, *P= .014, Student's t-test), and with greater variance (F
(14,14)= 3.768, P= .0184, F-test). (B) Elav > mnb larvae took longer than
controls to perform a self-righting task (Elav/+, 5.5 ± 1.16 s, n=15;
Elav > mnb, 12 ± 2.56 s; n=15; mean ± SEM, *P= .029, Student's t-test)
and with greater variance (F (14,14)= 4.802, P= .0059, F-test). Each point in
the plots (A, B) is from a different animal; horizontal lines indicate mean values.
(C) The age-dependent decline in climbing ability in a negative geotaxis assay
was steeper and showed greater variance for Elav > mnb adult flies than for
controls (F (3,84)= 13.8; ***P < .0001, repeated measures two-way ANOVA,
n=15 groups of flies); at 1 day old there was no difference in the percentage of
flies that climbed successfully (Elav/+, 90.59 ± 1.82%, n=15;
Elav > mnb ± 85.94 ± 1.46%, n=15; mean ± SEM, P= .8262, repeated
measures two-way ANOVA and Sidak's multiple comparison). Values plotted
are mean ± SEM, n=15 groups of 10 flies for each genotype. (D) Elav > mnb
flies had a shorter lifespan relative to controls (n=100 animals per genotype at
day 0, ***P < .0001, log-rank (Mantel-Cox) test).
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73 days; Elav > mnb, 38 days; Fig. 1D). These results indicate that
neuronal overexpression of mnb alone produced a motor deficit and
abnormal aging characterised by accelerated age-related locomotor
impairment and a shorter lifespan.
2.2. Overexpression of mnb caused neurodegeneration in adult flies
As DYRK1A triplication has been linked to degeneration of brain
neurons in AD-DS and in Ts65Dn mice (García-Cerro et al., 2017;
Wegiel et al., 2008), we tested the possibility that neuronal over-
expression of mnb is sufficient to cause neurotoxicity and age-related
neurodegeneration using two established assays of neurodegeneration
in adult flies (Lenz et al., 2013; McGurk et al., 2015). In the first, mnb
was overexpressed in the eye through development and adulthood
using the Glass multimer reporter driver (GMR-Gal4) (Ellis et al., 1993).
The GMR > mnb flies, but not control flies (GMR/+), had a reduced
eye surface area and a visible “rough eye” phenotype (Fig. 2A), both of
which indicate neural death and the resultant breakdown of the reg-
ularly spaced array of ommatidia making up the retina. In a second
assay, the EB1 driver (EB1-Gal4) was used to overexpress mnb in the
ellipsoid body (EB), a subpopulation of neurons within the central
complex of the brain implicated in locomotor control (Fig. 2B) (Diaper
et al., 2013). The EB cells also expressed membrane-bound GFP which
enabled their visualisation. At 1 day old, there was no difference in the
number of GFP-positive EB neurons between control (EB1/+) and
EB1 > mnb flies, whereas at day 40 the number of EB neurons was
significantly reduced in EB1 > mnb flies but not in control flies
(Fig. 2C). Therefore, neurotoxicity caused by mnb overexpression pro-
moted age-related neurodegeneration in a central neuron population.
2.3. Overexpression of mnb in motor neurons increased the number of
synaptic boutons at the larval NMJ
To investigate the effect of mnb overexpression on presynaptic
morphology, mnb was overexpressed in glutamatergic motor neurons of
Drosophila larvae using OK371-Gal4 (Mahr and Aberle, 2006). The
neuronal membranes were labelled with horseradish peroxidase (HRP).
The muscle is innervated by two motor neurons with functionally and
structurally distinct presynaptic boutons; 1 s (small) boutons have
higher excitation thresholds, higher basal probability of release and
induce larger post-synaptic potentials, while short-term and homeo-
static plasticity are largely mediated by 1b (big) boutons (Atwood et al.,
1997; Newman et al., 2017). These were differentiated by the stronger
postsynaptic expression of Discs large (Dlg) opposite 1b boutons (Lahey
et al., 1994) Analysis of the NMJ in the second abdominal larval seg-
ment, A2, showed that mnb overexpression affected the morphology of
the nerve terminals of only one of the motor neurons; it increased the
number of 1b boutons but did not alter the number of 1 s boutons
(Fig. 3A-B). The effect was not secondary to changes in muscle size, as
this did not differ (surface area of muscle 6: OK371/+,
44,752 ± 1407 μm2, n=15; OK371 > mnb, 44,681 ± 3684 μm2,
n=15, P= .9857).
Fig. 2. Neurotoxicity and age-related neurodegeneration caused by mnb
overexpression.
(A) (Left) Representative images of the eyes of control adult flies (GMR/+) and
flies with mnb overexpression driven in the eye by GMR-Gal4 (GMR > mnb).
(Right) The surface area of the eyes in GMR > mnb flies was reduced (GMR/+,
0.14 ± 0.005mm2, n=10; GMR > mnb, 0.09 ± 0.005mm2, n=10;
mean ± SEM, ***P < .0001, Student's t-test). Each point in the plot is from a
different animal, horizontal lines indicate means. (B) (Left) Representative
images of clusters of GFP-expressing ellipsoid body neurons in one brain
hemisphere, with and without mnb overexpression driven by EB1-Gal4, in 1 d
and 40 d old flies. Calibration bar is 10 μm. (Right) The number of cells did not
differ at 1 d (EB1 > mCD8-GFP; 32.59 ± 0.48, n=15 (black); EB1 > mCD8-
GFP, mnb; 31.47 ± 0.47, n=15 (grey); mean ± SEM, P= .757, repeated
measures two-way ANOVA and Sidak's multiple comparison) but decreased
between 1 and 40 d in EB1 > mCD8-GFP, mnb flies; (F (1,28)= 10.56; n=15;
P= .003, repeated measures two-way ANOVA). Values plotted are
mean ± SEM from 15 flies for each genotype.
Fig. 3. Overexpression of mnb in motor neurons increased the number of 1b
boutons.
(A) Representative images of motor nerve endings at the NMJ of muscle 6/7 in
the A2 segment of OK371/+ (top) and OK371 > mnb (bottom) larvae. The
neuronal membrane is labelled with HRP (green); type 1b boutons but not type
1 s boutons (arrowheads) are preferentially labelled with Dlg (magenta). Scale
bar is 25 μm. (B) OK371 > mnb NMJs had more 1b boutons (OK371/+,
24.93 ± 1.11, n=15; OK371 > mnb, 32.80 ± 1.52, n=15, mean ± SEM,
***P= .0003, Student's t-test) but there was no difference in the number of 1 s
boutons (OK371/+, 32.6 ± 2.62, n=15; OK371 > mnb, 38.6 ± 3.34,
n=15, mean ± SEM, P= .169, Student's t-test). Each value plotted is from a
different animal, horizontal lines indicate means. (For interpretation of the
references to colour in this figure legend, the reader is referred to the web
version of this article.)
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2.4. Overexpression of mnb in motor neurons altered basal synaptic
transmission at the larval NMJ
As neuronal overexpression of mnb increased the number of 1b
boutons at the larval NMJ, and because previous studies have im-
plicated Dyrk1a/mnb in the control of the recycling of neurotransmitter
vesicles (Chen et al., 2014; Kim et al., 2010; Murakami et al., 2012), we
investigated if spontaneous glutamate release was altered by recording
spontaneously occurring miniature excitatory junction potentials
(mEJPs) with intracellular microelectrodes. Since the muscle 6/7 NMJ
is innervated by 1b and 1 s boutons, mEJPs usually result from the
release of neurotransmitter vesicles from both types of boutons
(Newman et al., 2017). Our recordings revealed that mEJPs occurred
more frequently but were smaller in OK371 > mnb larvae (Fig. 4A-B).
The decrease in amplitude was not secondary to a change in the elec-
trical properties of the muscle as there was no difference in input re-
sistance (OK371/+, 3.37 ± 0.69MΩ, n=8; OK371 >
mnb=3.99 ± 0.99MΩ, n=8, P= .613) or resting potential
(OK371/+, −69.6 ± 1.48mV, n=8; OK371 > mnb,
−67.6 ± 1.55mV, n=8, P= .365). Although we did not directly
investigate the source of the more frequent smaller mEJPs, the notion
that they are due to the observed selective increase in the number of 1b
boutons is suggested by the fact that 1b-dependent mEJPs are smaller
than 1 s-dependent mEJPs (Newman et al., 2017). In parallel with the
changes in spontaneous synaptic events, there was a small (~11%)
decrease in the mean amplitude of electrically-evoked excitatory junc-
tion potentials (EJPs) caused by single stimuli applied to the nerve at a
low frequency (0.1 Hz) (Fig. 4C). There was no difference between EJPs
in mean rise time (OK371/+, 2.67 ± 0.178ms, n=8; OK371 > mnb,
3.23 ± 0.33ms, n=8, P= .728) or mean time constant of decay
(OK371/+, 44.9 ± 3.1ms, n=8; OK371 > mnb, 36.6 ± 4.6ms,
n=8, P= .154). The relatively small fall in EJP amplitude is likely to
reflect the smaller size of the 1b-dependent component of the EJP re-
lative to that of the 1 s-dependent component (Newman et al., 2017).
2.5. Overexpression of mnb in motor neurons slowed recovery from
frequency-dependent depression at the larval NMJ
To investigate the effects of neuronal mnb overexpression on re-
cycling of synaptic vesicles during electrically-evoked transmitter re-
lease, EJPs were evoked with pairs of electrical stimuli separated by
intervals of varying duration (10ms – 10 s) or with repeated trains of
10 stimuli applied at a high frequency (10 Hz, a frequency 100 times
higher than that at which the single EJPs were evoked) (Kauwe and
Isacoff, 2013). At control NMJs, paired pulses separated by intervals
shorter than 200ms caused depression of the amplitude of the second
EJP relative to that of the first and the depression was stronger for
shorter inter-stimulus intervals (Fig. 5A). The dependence of paired-
pulse depression on interval duration was unaltered in OK371 > mnb
larvae (Fig. 5A), indicating that mnb overexpression did not alter re-
lease from a readily releasable pool of vesicles (Regehr, 2012). When
transmitter release was evoked at control NMJs with a train of 10 sti-
muli at 10 Hz, there was rapid depression of the EJP amplitude by
~20% within the first 3 events (Fig. 5B). In the one-minute interval
before the next train, the EJP amplitude recovered fully so that the
amplitude of the first EJP in the second train was the same as in the first
train (Fig. 5B). This ability to recover did not wane during the re-
cording; the amplitude of the first EJP in each train did not differ be-
tween 8 trains (Fig. 5B). These effects are consistent with previous
studies (Kauwe and Isacoff, 2013) and confirm rapid depletion and
replenishment of the readily releasable pool of vesicles (Regehr, 2012).
However, the same pattern of nerve stimulation produced different
effects at OK371 > mnb NMJs (Fig. 5B). The percentage decrease in
EJP amplitude during each train was the same as at control NMJs, but
the depression was not fully reversed during the intervals between
trains, so that the first EJP in each train was smaller than the first EJP in
the preceding train. The depression in amplitude accumulated over the
8 trains, resulting in an overall fall of 10%. To confirm that the changes
in EJP amplitude were due to presynaptic changes in transmitter release
and were not postsynaptically mediated by a decrease in the unitary
depolarisations comprising each EJP, we measured the amplitudes of
200 mEJPs immediately before and 200 mEJPs immediately after the
series of trains at each NMJ. At both control and OK371 > mnb NMJs,
the cumulative distribution of mEJP amplitudes before and after a
series of trains was similar; although they were not identical, the ob-
served slight increase in the number of larger mEJPs cannot explain the
decline in EJP amplitude (Fig. 5C). These results show that mnb over-
expression slowed replenishment of the readily releasable pool of ve-
sicles, an effect consistent with the reported slowing of endocytosis of
transmitter vesicles by DYRK1A overexpression (Kim et al., 2010).
3. Discussion
This study demonstrated that neuronal overexpression of mnb, the
Drosophila ortholog of DYRK1A, is sufficient to induce motor impair-
ment, accelerate age-related decline in motor performance, shorten
lifespan and cause age-dependent neurodegeneration. This study also
found that neuronal mnb overexpression at a glutamatergic synapse
alters presynaptic structure, modifies basal synaptic transmission and
Fig. 4. Overexpression of mnb in motor neurons altered basal synaptic trans-
mission.
(A) Representative voltage recordings (3 s traces) from NMJs of OK371/+
(black) and OK371 > mnb (grey) larvae showing spontaneous mEJPs recorded
at a membrane potential of −70mV. (B) Cumulative frequency distributions of
mEJP amplitude (left) and inter-mEJP interval (right) (1600 events, 200 from
each of 8 NMJ recordings). OK371 > mnbmEJPs were smaller (***P < .0001)
and more frequent (***P < .0001), Kolmogorov-Smirnov test. (C) (Left)
Representative image of a single electrically-evoked EJP at an OK371/+ NMJ
and an OK371 > mnb NMJ at a membrane potential of −70mV. (Right) The
median EJP amplitude (horizontal line) was reduced in OK371 > mnb NMJs
(OK371/+, 51.26mV, n=8; OK371 > mnb, 45.55mV, n=8; mean ± SEM,
*P= .0281). Each point plotted is from a different animal.
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delays recovery from short-term synaptic depression. This provides
useful information about the gene's function and the pathological ef-
fects of increased expression in a model system. However, it is im-
portant to note that this does not represent a high-fidelity recapitulation
of DS or the complexity of the human DYRK1A locus, because Gal4-
mediated overexpression of a specific isoform does not accurately re-
plicate the expression level or pattern caused by triplication of a whole
genomic region of human chromosome 21.
People with DS have impaired motor skills which are evident from
childhood and are caused by abnormal development of the nervous
system (Malak et al., 2015; Stagni et al., 2018). Later, in middle age,
they undergo faster age-dependent motor decline, which is an early
marker of future dementia, comorbidities and mortality, and is likely
caused by histopathological changes in the brain (Anderson-Mooney
et al., 2016; Buchman and Bennett, 2011). The life expectancy of people
with DS is about 28 years shorter than the general population (O'Leary
et al., 2018). By taking advantage of the relatively short life cycle of
Drosophila and transgenic overexpression of mnb in neurons, we have
demonstrated a potential role for neuronal DYRK1A overexpression in
the accelerated age-dependent decline of motor function and shortening
of life expectancy in DS. The genetic basis of these aspects of DS are
more difficult and costly to explore in mouse models of DS, due to the
time required to study aged mice. Our finding that mnb overexpression
causes age-related neurodegeneration confirms previous studies in-
ferring a link between DYRK1A overexpression and degeneration and
loss of neurons (Duchon and Herault, 2016; García-Cerro et al., 2017;
Watson-Scales et al., 2018; Wegiel et al., 2008), which is associated
with faster age-related decline in motor and cognitive function in DS
and AD-DS. Our results also reinforce the conclusion from earlier stu-
dies with adult mice overexpressing DYRK1A or Dyrk1a, alone or as part
of a chromosomal segment, that triplication of DYRK1A is likely to
contribute to motor deficits in DS (Altafaj et al., 2001; Arque et al.,
2013; Garcia-Cerro et al., 2018; Martínez de Lagrán et al., 2004; Ortiz-
Abalia et al., 2008; Souchet et al., 2014; Watson-Scales et al., 2018).
In addition to the smaller brain size and fewer brain neurons in DS
and mouse models of DS, there are alterations in the structure of brain
synapses that are predicted to modify synaptic function (Contestabile
et al., 2017; Dierssen, 2012; Stagni et al., 2018). A previous study
Fig. 5. mnb overexpression in motor neurons slowed
recovery from frequency-induced depression.
(A) (Left) Representative pairs of stimuli evoked EJPs
at OK371/+ (black) and OK371 > mnb (grey)
NMJs. Dashed lines compare the first EJP (EJP1) and
dotted lines compare the second EJP (EJP2). (Right)
Plots of paired-pulse ratio (EJP2/EJP1,
mean ± SEM, n=8 for each genotype) against
inter-pulse interval reveal no difference in synaptic
depression (F (9, 126)=0.1343; n=8; P= .9987,
repeated measures two-way ANOVA). (B) High-fre-
quency stimulation protocol. 10 EJPs were evoked at
0.1 Hz to establish a mean baseline amplitude fol-
lowed by 8 trains of 10 EJPs at 10 Hz, at one minute
intervals. (Left) Representative traces of train 1
(upper) and train 8 (lower) recorded from OK371/+
and OK371 > mnb NMJs. Dashed lines compare
EJP1 in each train. (Right) Plots of EJP amplitude
during trains 1 and 8, expressed as a fraction of
baseline amplitude (mean ± SEM, n=8 for each
genotype). During the first train, the decline in EJP
amplitude was unaffected by genotype (F (1,
14)= 0.22, P= .6486, repeated measures two-way
ANOVA). In the eighth train, EJPs were smaller at
OK371 > mnb NMJs (F (1,14)= 4.98, P= .0426)
but the rate of decline during the 8th train was not
different (F (9, 126)= 0.99, P= .4540, repeated
measures two-way ANOVA). (C) Cumulative fre-
quency distributions of mEJP amplitudes (n=1600
from 8 NMJ recordings) from immediately before
(solid line) and immediately after (dashed line) the
trains, for OK371/+ (left) and OK371 > mnb (right)
NMJs; after the trains, a minority of mEJPs were
larger in both OK371/+ (*P= .0117) and
OK371 > mnb (*P= .018) NMJs (log-rank (Mantel-
Cox) test).
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showed that DYRK1A overexpression in mice changes postsynaptic
morphology in the cortex and in cultured cortical neurons by reducing
the number and length of dendrites and by reducing the number of
dendritic spines but elongating their shape (Martinez de Lagran et al.,
2012). It also decreased the number of synapses formed. Our study
shows that mnb overexpression changes presynaptic structure and that
this happens in a neuron-specific manner; mnb overexpression in the
two glutamatergic motoneurons innervating the larval NMJ increased
the number of 1b boutons without changing the number of 1 s boutons.
These data are consistent with a previous study which demonstrated
that reduced levels of mnb caused a decrease, and increased levels of the
mnb-F transcript an increase, in the number of boutons at the NMJ
(Chen et al., 2014), but did not differentiate between 1b and 1 s bou-
tons.
The cognitive and motor deficits in DS arise from aberrant in-
formation processing in the brain that is likely due, in part, to changes
in synaptic transmission or synaptic plasticity. Individuals with DS have
impaired synaptic plasticity in the motor cortex (Battaglia et al., 2008).
Our finding that mnb overexpression slows replenishment of the readily
releasable pool of vesicles, and also modifies basal synaptic transmis-
sion, confirms a previous suggestion that DYRK1A overexpression
contributes to synaptic dysfunction and cognitive deficits associated
with DS, made on the basis of the observed slowing of endocytosis of
transmitter vesicles in cultured mouse hippocampal neurons over-
expressing human DYRK1A (Kim et al., 2010). The effects of DYRK1A
on synaptic function may be splice variant specific as we found that
overexpression of the mnb-H transcript caused a decrease in mEJP and
EJP amplitude, whereas overexpression of mnb-F in a previous study did
not alter mEJP or EJP amplitude at the larval NMJ (Chen et al., 2014).
The effects of neuronal mnb overexpression on larval NMJ function
replicate some, but not all, the documented changes in glutamatergic
synaptic transmission in the brain of mouse models of DS. These include
a decrease in the amplitude of spontaneous excitatory postsynaptic
currents (sEPSCs) in neocortical neurons of Ts65Dn mice (Cramer et al.,
2015), compromised glutamate release in response to stimuli trains at
hippocampal CA1 synapses of Ts1Cje mice (Siarey et al., 2005) and a
decrease in EPSC amplitude in hippocampal CA3 neurons of Ts65Dn
mice (Hanson et al., 2007). However, in contrast to the increase in
mEJP frequency caused by mnb overexpression at the larval NMJ,
electrophysiological studies have found a decrease in the frequency of
mEPSCs in hippocampal CA3 neurons of Ts65Dn mice, sEPSCs in neo-
cortical neurons of Ts65Dn mice and sEPSCs in neurons derived from
trisomy 21 induced pluripotent stem cells, or no change in mEPSC
frequency in the prefrontal cortex of TgDyrk1a mice or mossy fibre-CA3
synapses in Tc1 mice (Contestabile et al., 2017).
Our study further elucidates the effect of DYRK1A overexpression in
a model system, giving insight into the contribution of increased dosage
to various DS phenotypes. It supports the future development of phar-
macological inhibitors of DYRK1A as treatments for multiple aspects of
DS and DS-AD (Duchon and Herault, 2016; Stringer et al., 2017). Fur-
ther work is necessary to fully understand interactions between
DYRK1A and other triplicated Hsa21 genes in DS, in specific cell types
and during defined periods of development and aging.
4. Materials and methods
4.1. Animals
Flies were raised with a 12 h:12 h light dark cycle with lights on at
ZT 0 (Zeitgeber time) on standard Drosophila medium (0.7% agar, 1.0%
soya flour, 8.0% polenta/maize, 1.8% yeast, 8.0% malt extract, 4.0%
molasses, 0.8% propionic acid, 2.3% nipagen) at 25 °C. Flies were
transferred to vials containing fresh medium twice weekly. The OK371-
Gal4 (Bloomington stock center numbers: 26160), Elav-Gal4 (87060),
GMR-Gal4 (9146) flies were obtained from the Bloomington Drosophila
Stock Centre. Canton Special white- (CSw-) flies were a gift from Dr. Scott
Waddell (University of Oxford), UAS-mnb flies (minibrain-H, CG42273)
were kindly provided by Dr. Kweon Yu (Korea Research Institute of
Bioscience and Biotechnology), EB1-Gal4; UAS-mCD8-GFP flies were
donated by Dr. Frank Hirth (Kings College London).
4.2. Behaviour
mnb expression was driven throughout the nervous system using
Elav-Gal4 (Robinow and White, 1991) for experiments investigating
behaviour of wandering third instar larvae, the number of boutons at
the larval NMJ, and synaptic transmission at the larval NMJ. All be-
havioural experiments took place at 25 °C. Larval locomotor experi-
ments were conducted on a 9.5 cm petri dish containing 1.6% agarose.
A single third instar wandering larva was selected, washed in a drop of
distilled H2O, transferred to the agarose and allowed 30 s to acclima-
tise. To analyse free movement, the dish was placed over a 0.5 cm grid
and the number of lines the larva crawled across in one minute was
counted by eye. The self-righting assay was conducted as described
elsewhere (Lowe et al., 2018; Picao-Osorio et al., 2015); the larva was
gently rolled onto its back on the agarose using a fine moistened
paintbrush, held for one second and released, and the time for it to right
itself was recorded.
The negative geotaxis assay was performed as described previously
(Ali et al., 2011). A cohort of 10 flies was transferred without anaes-
thesia to an empty 9.5 cm tube with a line drawn 2 cm from the top.
After 1min acclimatisation, the vial was sharply tapped 3 times to
knock the flies to bottom. The number of flies to climb past the line
within 10 s was recorded. 15 cohorts of 10 flies were tested for each
genotype. Age-dependent changes in climbing were assessed by re-
peating the negative geotaxis assay at 10, 20 and 30 days post-eclosure
(Gargano et al., 2005). For the survival assay, 10 cohorts of 10 once-
mated females were transferred to a vial of fresh food twice weekly and
the number of surviving flies recorded at each transfer.
4.3. Antibody staining and visualisation at the NMJ
Wandering third instar larvae were dissected in ice-cold, Ca2+-free
HL3.1-like solution (in mM: 70 NaCl, 5 KCl, 10 NaHCO3, 115 sucrose, 5
trehalose, 5 HEPES, 10 MgCl2) to produce a larval “fillet” (Brent et al.,
2009). The fillet was fixed for 30min in 4% paraformaldehyde (Sigma
Labs), washed three times in 1% Triton-X (Sigma Labs) and blocked for
one hour in 5% normal goat serum (Fitzgerald Industries) and 1%
Triton-X at room temperature. It was incubated overnight in 1/500
mouse FITC-conjugated anti-horseradish peroxidase (HRP-FITC)
(Jackson Immunoresearch Laboratories, 115–035-003) and 1/500
rabbit anti-Discs large (Dlg) (Biocompare, ABIN1387516) primary an-
tibody, then for two hours in 1/500 AlexaFluor 633-conjugated goat
anti-mouse secondary antibody (ThermoFisher Scientific, A-21052) at
room temperature. Each fillet was washed and mounted on a coverslip
in Vectashield (Vector Laboratories). Z-series of NMJs were imaged on a
Leica SP5-II confocal laser-scanning microscope using an oil immersion
40× objective. The number of boutons at the NMJ of muscle 6/7 in
segment A2 was counted manually. ImageJ (rsb.info.nih.gov/ij/) was
used to manually outline muscle 6 and hence calculate their area.
4.4. Neurotoxicity
Overexpression of mnb was driven in the eye using the Glass mul-
timer reporter (GMR-Gal4). Images of the whole head of 1–2 day old flies
were taken via a Zeiss AxioCam MRm camera attached to a stereo-
microscope (Zeiss SteREO Discovery.V8, up to 8× magnification), and
the surface area of the eye was calculated by manually outlining the eye
in ImageJ (rsb.info.nih.gov/ij/). Overexpression of mnb in GFP-tagged
ellipsoid body (EB) ring neurons was achieved by crossing EB1-Gal4;
UAS-mCD8-GFP flies with UAS-mnb flies. Following published methods
(Williamson and Hiesinger, 2010), adult brains were dissected, fixed for
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30min in 4% paraformaldehyde and mounted on a coverslip in Vec-
tashield (Vector Laboratories). Slides were imaged on a Leica SP5-II
confocal laser scanning microscope using an oil immersion 40×ob-
jective. A Z-stack of 25 images at 1 μm increments was captured and
combined into a 3-D projection using ImageJ (rsb.info.nih.gov/ij/);
analysis was performed by scrolling through all 25 images and counting
the number of cells in one brain hemisphere.
4.5. Electrophysiology
Wandering third instar larvae were dissected as for antibody
staining. The motor nerves were severed just below the ventral ganglion
and the brain was removed. CaCl2 (1mM) was added to the bath so-
lution for intracellular recording from muscle 6 of abdominal segments
2–4. Most recordings were made in the presence of thapsigargin (2 μM),
which minimises contraction and hence facilitates intracellular re-
cording, without affecting amplitudes of mEJPs or EJPs (Guerrero et al.,
2005; Newman et al., 2017). Sharp microelectrodes (thick-walled bor-
osilicate capillaries, pulled on a Sutter Flaming/Brown P-97 micropip-
ette puller) were filled with 3M KCl and had resistances of 20–30MΩ.
For recording of stimulus evoked excitatory junction potentials (EJPs),
severed nerves were drawn into a thin-walled glass-stimulating pipette
and stimulated with square-wave voltage pulses (0.1ms, 10 V, A-M
Systems Model 2100 Isolated Pulse Simulator), 10 times at 0.1 Hz. EJPs
and spontaneously-occurring miniature EJPs (mEJPs) were recorded at
a controlled room temperature of 22–25 °C with a Geneclamp 500
amplifier (Axon Instruments) and were further amplified with a LHBF-
48× amplifier (NPI Electronic). The membrane potential was allowed
to stabilise for one minute, the initial value was recorded, and then set
to −70mV by injecting current with the Geneclamp 500 amplifier. The
muscle input resistance was measured by injecting current using the
Axon Geneclamp 500, to bring the membrane potential to −100, −80,
−60 and− 40mV, and subtracting the electrode resistance from the
slope of the resulting voltage/current graph. Voltage signals were low-
pass filtered at 1.67 kHz (10 kHz 4 pole Bessel on Geneclamp 500,
1.7 kHz 8-pole Bessel on LHBF-48×) and digitised at 25 kHz by a CED-
1401 plus A/D interface (Cambridge Electronic Design, UK) using
Spike2 software (v. 5.13) (CED, Cambridge, UK). Recordings were
discarded if the initial resting membrane potential was more positive
than −60mV or varied by>10% throughout the recording. Synaptic
potentials were analysed off line using Strathclyde Electrophysiology
Software WinEDR (v3.5.2) and GraphPad Prism (v.6). All synaptic
events were verified manually.
Amplitudes and intervals of mEJPs were compared by creating a
cumulative distribution for each genotype of 1600 measurements across
8 animals, with each animal contributing 200 values. To analyse the
mEJP waveform, a mean mEJP was constructed for each recording from
events showing a single clear peak and a smooth decay, so as to prevent
distortion of the waveform by closely occurring mEJPs. A single ex-
ponential was fitted to the decay of the mean mEJP and the 10–90%
rise-time was measured. Time zero for the exponential fit was set to the
time at the peak of the mEJP. EJPs were analysed by forming a mean of
10 events, measuring the 10–90% rise-time of the mean event, and
fitting the decay with the sum of three exponentials (time zero was set
at the time of the peak). A mean weighted time constant of decay was
calculated as A1.τ1+A2.τ2+A3.τ3, where A1, A2 and A3 are the frac-
tional amplitudes of the three components, and τ1, τ2 and τ3 are their
time constants.
For paired pulse analysis, two EJPs were evoked, separated with
intervals varying in duration between 0.01 and 10 s. The amplitude of
the second event was calculated as a fraction of the amplitude of the
first. Pairs of stimuli were separated by 30 s. For high–frequency sti-
mulation, trains of 10 events evoked at 10 Hz were repeated 8 times at
1min intervals. The amplitude of each event was expressed as a fraction
of a baseline value, defined as the mean amplitude of 10 single EJPs
evoked at 0.1 Hz. To compare mEJP amplitude before and after the
trains, 200 mEJP amplitudes were measured immediately before the
first train, and another 200 immediately after the eighth train. The
measured values were pooled from 8 NMJs for each genotype and cu-
mulative amplitude distributions compared.
4.6. Statistical analysis
Statistical analysis was conducted in GraphPad Prism (v. 6, La Jolla,
CA). Data were tested for normality using the Kolmogorov-Smirnov
test; where appropriate means were compared using Student's unpaired
t-test, or medians were compared using a Mann-Whitney U test. EJPs
evoked by pairs or trains of stimuli were compared using repeated
measures 2-way ANOVA. Cumulative distributions were compared with
a Kolmogorov-Smirnov test. Survival curves were compared with a
Mantel-Cox test. Data are given as median or mean ± SEM. n is given
per genotype. An α level of P < .05 was considered significant.
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